We are live on ! Find out more
SC

Salzman & Co Portfolio holdings

AUM $29.7M
1-Year Est. Return 12.12%
This Fund
S&P 500
This Quarter Est. Return
+15.84%
1 Year Est. Return
-12.12%
3 Year Est. Return
-15.72%
5 Year Est. Return
10 Year Est. Return
AUM
$112M
AUM Growth
+$48.9M
Cap. Flow
+$36.8M
Cap. Flow %
32.89%
Top 10 Hldgs %
100%
Holding
7
New
4
Increased
1
Reduced
2
Closed

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$6.7M
2
CTSH icon
Cognizant
CTSH
+$2.98M

Sector Composition

Rank Sector Weight
1 Healthcare 30.37%
2 Technology 28.89%
3 Energy 24.69%
4 Consumer Staples 15.99%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
1
Cognizant
CTSH
$21.2B
$32.3M 28.89%
786,130
-80,162
-9% -$2.98M
SU icon
2
Suncor Energy
SU
$73.7B
$27.6M 24.69%
+771,027
New +$25.6M
COR icon
3
Cencora
COR
$59.9B
$17.8M 15.97%
292,111
+45,739
+19% +$2.67M
EW icon
4
Edwards Lifesciences
EW
$49.4B
$16.1M 14.39%
1,385,856
-572,820
-29% -$6.7M
PM icon
5
Philip Morris
PM
$301B
$9.87M 8.83%
+113,956
New +$9.96M
MJN
6
DELISTED
Mead Johnson Nutrition Company
MJN
$8M 7.16%
+107,714
New +$8.08M
SIG icon
7
Signet Jewelers
SIG
$3.56B
$72K 0.06%
+1,000
New +$70.9K

Similar funds

Salzman & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Salzman & Co held 7 positions worth $112M, up 78% from $62.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Salzman & Co deployed $36.8M of net new capital in Q3 2013, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Suncor Energy: 771,027 shares worth $27.6M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 57% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $6.7M trimmed.

  • Salzman & Co's largest Q3 2013 buy was Suncor Energy: 771,027 shares worth $27.6M.
  • Salzman & Co added most to Cencora in Q3 2013, an estimated $2.67M increase.
  • Salzman & Co's biggest Q3 2013 reduction was Edwards Lifesciences, cutting an estimated $6.7M.
  • Salzman & Co's ten largest holdings make up 100% of its $112M portfolio in Q3 2013.
  • Salzman & Co opened 4 new positions and closed 0 in Q3 2013.
  • Salzman & Co's portfolio value rose 78% quarter-over-quarter to $112M.

Based on Salzman & Co's 13F filing for Q3 2013, filed 14 Nov 2013.